This is a working overview of GLP-1 receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-02-01. Anything still debated is marked as such rather than presented as settled.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Analytical characterization of tirzepatide typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) for purity assessment and peptide mapping. Mass spectrometry, often coupled with electrospray ionization, confirms molecular weight and sequence integrity. Amino acid analysis and capillary electrophoresis may also be used to detect impurities or degradation products. These methods are essential for batch release and stability studies.
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Others interpret the agent intellect as a single divine being, perhaps the unmoved mover, Aristotle's God. A third interpretation relies on the theory that an individual form is capable of having properties of its own. According to this interpretation, the soul is a property of the body, but the ability to think is a property of the soul itself, not of the body. If that is the case, then the soul is the body's form and yet thinking need not involve any bodily organ.
=== Conductors === According to Gauss’s law, a conductor at equilibrium carrying an applied current has no charge on its interior. Instead, the entirety of the charge of the conductor resides on the surface, and can be expressed by the equation:
==== The five components of recognition ==== Adorno states that a start to understanding the recognition in respect of any particular song hit may be made by drafting a scheme that divides the experience of recognition into its different components. All the factors people enumerate are interwoven to a degree that would be impossible to separate from one another in reality. Adorno's scheme is directed towards the different objective elements involved in the experience of recognition:
Sources: en.wikipedia.org
==== Improvement in batteries ==== Improvements can be seen in the electrical conductivity and charge retention of batteries when QDs are added to anodes. In a comparison made between Pure MnO and MnO doped with quantum dot for the capacity of charge and discharge in (mAh/g) against the number of cycles, it can be seen that battery capacity, or the amount of energy that a battery can hold, is higher in MnO quantum dot-doped batteries than in batteries without, and remains higher after many charging/discharging cycles, taking in consideration a current density of Ag^-1. There exists a constant average difference of around 250 mAh/g in favor of the doped compound for both charge and discharge comparisons, comparing from 0 to 60 cycles, going from 1000 mAh/g to 450 mAh/g in the first 60 cycles for the doped compound, and from 750 mAh/g to 200 mAh/g for the pure MnO. A comparison using Graphene Quantum Dots for a NP-SiAl compound not only shows higher discharge capacities but also an improved electrochemical impedance spectroscopy plot, indicating that the battery has better electrical conductivity. For the case of the NP-SiAl/GQDs, the value of -Z´´/ohm reaches a peak of 300, for 250 Z´/ohm, while for the pure NP-SiAl, the peak of 300 -Z´´/ohm is reached at 650 Z´/ohm.
==== Afonso Dias' acquittal ==== "The silence of Afonso Dias made us think of the worse. The only explanation that I find for him to continue to not talk is that he is hiding something even worse than what is being discussed. (...) Afonso has the legal right of being silent, but not the moral right (...) He still has time to regret. We have the remote hope that Afonso Dias comes to his senses as a man and says what happened." - Ricardo Sá Fernandes, 2012In Dias' trial, the following facts were given as proven by the judge Carla Fraga: In the day of Mendonça's disappearance, a man introduced an 11-year-old boy to the prostitute, Alcina Dias. According to the court's hypothesis, it could have been another man and another boy. Mendonça got in Dias' car and left his bike next to the meeting place. Seven witnesses confirmed that Mendonça had two meetings with Dias. Dias was going to introduce Mendonça and João André Mendonça to the prostitutes. However, the court said it was not proven that Dias had formulated a plan for Mendonça to have sexual relations with the prostitutes. Dias ordered that João André Mendonça did not tell anyone about the invitation that he made to meet with the prostitutes, as he was afraid of "becoming a suspect." Such proven facts did not avoid the defendant's acquittal in March 2012.
==== Quantum dot only solar cells ==== Aromatic self-assembled monolayers (SAMs) (such as 4-nitrobenzoic acid) can be used to improve the band alignment at electrodes for better efficiencies. This technique has provided a record power conversion efficiency (PCE) of 10.7%. The SAM is positioned between ZnO–PbS colloidal quantum dot (CQD) film junction to modify band alignment via the dipole moment of the constituent SAM molecule, and the band tuning may be modified via the density, dipole and the orientation of the SAM molecule.
The Gaza Strip, now a part of the State of Palestine, has previously been under Ottoman, British, and Egyptian control. Israel directly occupied the entirety of Gaza from 1967 to 1993, when the Palestinian Authority assumed civil control of most of the region. In 2005, Israel disengaged from the Gaza Strip, the same year the militant group Hamas won parliamentary elections in the region. Decades-long US diplomacy on Israel and the Palestinians have not produced successful resolutions in the conflict. The Gaza Strip has seen a major scale of destruction since the beginning of the Gaza war in October 2023. Civilians who were internally displaced have been able to return to their homes since the ceasefire which began on 15 January 2025. The cost of rebuilding Gaza has been estimated to be in the tens of billions of dollars. Calls to displace Palestinians from Gaza mirror demands made by those in the Israeli far-right who have often called for ethnically cleansing Palestinian land to open it up to foreign settlement.
Sources: en.wikipedia.org
=== Police corruption accusation === In 2007, a representative of Innocence en Danger, a global NGO launched in 1999 to combat pedophilia, at the time with international offices in Germany, France and the United States, said that "the corrupt police [of Portugal] don't care" about the problem, and cited as an example the cases of Mendonça and Madeleine McCann. After three years, the NGO gave up trying to open an office in Portugal, saying that they were pressured by local authorities.
{\displaystyle {\begin{aligned}E_{\textrm {confinement}}&={\frac {\hbar ^{2}\pi ^{2}}{2a^{2}}}\left({\frac {1}{m_{\rm {e}}}}+{\frac {1}{m_{\rm {h}}}}\right)={\frac {\hbar ^{2}\pi ^{2}}{2\mu a^{2}}}\\[6px]E_{\textrm {exciton}}&=-{\frac {1}{\varepsilon _{\rm {r}}^{2}}}{\frac {\mu }{m_{\rm {e}}}}R_{y}=-R_{y}^{*}\\[6px]E&=E_{\textrm {bandgap}}+E_{\textrm {confinement}}+E_{\textrm {exciton}}\\&=E_{\textrm {bandgap}}+{\frac {\hbar ^{2}\pi ^{2}}{2\mu a^{2}}}-R_{y}^{*}\end{aligned}}}
== See also == Butyric acid α-Aminobutyric acid (homoalanine) 2-Hydroxybutyric acid (α-hydroxybutyric acid) Other oxobutanoic acids 3-Oxobutanoic acid (acetoacetic acid) 4-Oxobutanoic acid (succinic semialdehyde)
Emdogain which has been shown to significantly improve probing attachment levels (1.1mm) and periodontal pocket depth reduction (0.9mm) when compared to a placebo or control materials. Resorption rates ranging from six to 24 weeks depending on its different chemical structures. With the resorbable membrane used, the membrane will bio-degrade. There is no need for a second surgery to remove the membrane, this will prevent any disruption to the healing process of the regenerated tissues. A synthetic resorbable membrane (eg: Powerbone Barrier Membrane) is an ideal alternative to the resorbable collagen material. Randomised clinical trials compared the stability of augmented bone between a synthetic resorbable membrane and a collagen membrane with guided bone regeneration simultaneous to dental implant placement in the aesthetic zone in terms of facial bone thickness. Success depends on several factors: osteoblasts being present at the site, a sufficient blood supply, stabilisation of the graft during healing, and soft tissue not being under tension.
At the age of 13, Boyd Orr won a bursary to Kilmarnock Academy, a significant achievement as such bursaries were then rare. The new school was some 20 miles (32 km) from his home in West Kilbride, but his father owned a quarry about two miles (3 km) from the academy, and John was provided with accommodation nearby. His family cut short his education at the academy because, at the expense of his school attendance, he was spending time with the quarry workers, who let him work the machinery, and from whom he picked up a "wonderful vocabulary of swear words". After four months he returned to the village school in West Kilbride where he continued his education under the inspirational tutelage of Headmaster John G. Lyons. There he became a pupil teacher at a salary of £10 for the first year, and £20 for the second. This was a particularly demanding time for the young Boyd Orr, as in addition to his teaching duties, and studying at home for his university entrance and teacher-training qualifications, he also had to work every day in his father's business.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
It separates molecules by hydrophobicity, which is effective for distinguishing an intact peptide from truncated or chemically modified forms. A C18 column with an acidic water-organic mobile phase is a standard configuration.